221 related articles for article (PubMed ID: 12887811)
21. Outcome of peptic ulcer bleeding, nonsteroidal anti-inflammatory drug use, and Helicobacter pylori infection.
Ramsoekh D; van Leerdam ME; Rauws EA; Tytgat GN
Clin Gastroenterol Hepatol; 2005 Sep; 3(9):859-64. PubMed ID: 16234022
[TBL] [Abstract][Full Text] [Related]
22. Non-Helicobacter pylori ulcer disease in rheumatoid arthritis patients receiving long-term NSAID therapy.
Mizokami Y; Narushima K; Shiraishi T; Otsubo T; Narasaka T; Matsuoka T
J Gastroenterol; 2000; 35 Suppl 12():38-41. PubMed ID: 10779216
[TBL] [Abstract][Full Text] [Related]
23. [Gastropathy caused by non-steroidal anti-inflammatory agents and its association with Helicobacter pylori].
Rodríguez-Hernández H; Jacobo-Karam JS; Jáquez-Quintana JO; Avila-Romero HG; Galván-Román L; Lara-Miranda SC; Sánchez-Anguiano LF
Rev Invest Clin; 2003; 55(3):254-9. PubMed ID: 14515669
[TBL] [Abstract][Full Text] [Related]
24. [Clinical features and diagnosis of non-steroidal anti-inflammatory drugs induced ulcers of the stomach].
Watari J; Kim Y; Yokoyama S; Hori K; Miwa H
Nihon Rinsho; 2011 Jun; 69(6):1016-23. PubMed ID: 21688621
[TBL] [Abstract][Full Text] [Related]
25. How do NSAIDs cause ulcer disease?
Wallace JL
Baillieres Best Pract Res Clin Gastroenterol; 2000 Feb; 14(1):147-59. PubMed ID: 10749095
[TBL] [Abstract][Full Text] [Related]
26. Role of Helicobacter pylori infection in peptic ulcer haemorrhage.
Morgando A; Giordanino C; Baronio M; Pellicano R; Rizzetto M
Minerva Med; 2006 Feb; 97(1):47-50. PubMed ID: 16565698
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of Helicobacter pylori infection in duodenal ulcer and gastro-duodenal ulcer diseases in Taiwan.
Chen TS; Luo JC; Chang FY
J Gastroenterol Hepatol; 2010 May; 25(5):919-22. PubMed ID: 20074147
[TBL] [Abstract][Full Text] [Related]
28. Is non-Helicobacter pylori, non-NSAID peptic ulcer a common cause of upper GI bleeding? A prospective study of 977 patients.
Chan HL; Wu JC; Chan FK; Choi CL; Ching JY; Lee YT; Leung WK; Lau JY; Chung SC; Sung JJ
Gastrointest Endosc; 2001 Apr; 53(4):438-42. PubMed ID: 11275883
[TBL] [Abstract][Full Text] [Related]
29. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
Goldstein JL; Huang B; Amer F; Christopoulos NG
Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
[TBL] [Abstract][Full Text] [Related]
30. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
Limmer S; Ittel TH; Wietholtz H
Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
[TBL] [Abstract][Full Text] [Related]
31. Nonsteroidal antiinflammatory drug-associated gastric ulcers do not require Helicobacter pylori for their development.
Laine L; Marin-Sorensen M; Weinstein WM
Am J Gastroenterol; 1992 Oct; 87(10):1398-402. PubMed ID: 1415094
[TBL] [Abstract][Full Text] [Related]
32. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: synergy or null effect?
Am J Manag Care; 2001 Sep; 7(12 Suppl):S402-3. PubMed ID: 11570032
[TBL] [Abstract][Full Text] [Related]
33. Interactions between Helicobacter pylori and other risk factors for peptic ulcer bleeding.
Stack WA; Atherton JC; Hawkey GM; Logan RF; Hawkey CJ
Aliment Pharmacol Ther; 2002 Mar; 16(3):497-506. PubMed ID: 11876703
[TBL] [Abstract][Full Text] [Related]
34. Relative contribution of mucosal injury and Helicobacter pylori in the development of gastroduodenal lesions in patients taking non-steroidal anti-inflammatory drugs.
Hawkey CJ; Naesdal J; Wilson I; Långström G; Swannell AJ; Peacock RA; Yeomans ND
Gut; 2002 Sep; 51(3):336-43. PubMed ID: 12171953
[TBL] [Abstract][Full Text] [Related]
35. Helicobacter pylori-negative duodenal and pyloric ulcer: role of NSAIDs.
Hyvärinen H; Salmenkylä S; Sipponen P
Digestion; 1996; 57(5):305-9. PubMed ID: 8886573
[TBL] [Abstract][Full Text] [Related]
36. [Significance of Helicobacter pylori infection and nonsteroidal anti-inflammatory drugs in patients with bleeding from upper part of the gastrointestinal tract].
Golubović G; Tomasević R; Radojević B; Pavlović A; Dugalić P
Vojnosanit Pregl; 2007 Jul; 64(7):445-8. PubMed ID: 17821917
[TBL] [Abstract][Full Text] [Related]
37. [Role of non-steroidal anti-inflammatory drugs on upper gastrointestinal bleeding].
Sułek M; Steinbrich-Zoller M; Dudek A; Jancelewicz J; Niedziałek D
Pol Merkur Lekarski; 2005 Nov; 19(113):642-5. PubMed ID: 16498802
[TBL] [Abstract][Full Text] [Related]
38. Risk and preventive factors of low-dose aspirin-induced gastroduodenal injuries: a comprehensive review.
Shiotani A; Manabe N; Kamada T; Fujimura Y; Sakakibara T; Haruma K
J Gastroenterol Hepatol; 2012 Apr; 27 Suppl 3():8-12. PubMed ID: 22486865
[TBL] [Abstract][Full Text] [Related]
39. Clinical evaluation of hemorrhagic gastroduodenal ulcer in the elderly: is Helicobacter pylori infection a risk factor for hemorrhage?
Domon K; Hirano N; Otsuka T; Fujitsuka Y; Takeuchi M; Kikuchi Y; Nakano S; Igarashi Y
Dig Endosc; 2012 Sep; 24(5):319-24. PubMed ID: 22925283
[TBL] [Abstract][Full Text] [Related]
40. Implication of antithrombotic agents on potential bleeding from endoscopically determined peptic ulcers, incidentally detected as surrogate markers for nsaids-associated ulcers complication.
Miyake K; Kusunoki M; Ueki N; Nagoya H; Kodaka Y; Shindo T; Kawagoe T; Gudis K; Futagami S; Tsukui T; Nakamura H; Sakamoto C
Dig Endosc; 2013 Jan; 25(1):25-31. PubMed ID: 23286253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
